Development of a Hospital Compounded, Taste-Masked, Temozolomide Oral Suspension and 5-Year Real-Life Experience in Treating Paediatric Patients

The development of oral pediatric forms by pharmaceutical companies is still insufficient. In fact, many drugs used in paediatric oncology, such as temozolomide, are not labeled and adapted for paediatric use. Temozolomide (TMZ) is an alkylating agent used as the standard of care for many adult and...

Descripción completa

Detalles Bibliográficos
Autores principales: Annereau, Maxime, Hinterlang, Mélanie, Bienayme, Hugues, Vassal, Gilles, Pinon, Antoine, Schmitt, Mathieu, Denis, Lucas, Lemarchand, Caroline, Martin, Laurent, Lemare, François, Abbou, Samuel, Bastid, Jérémy, Tortolano, Lionel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146721/
https://www.ncbi.nlm.nih.gov/pubmed/35631381
http://dx.doi.org/10.3390/ph15050555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146721/
https://www.ncbi.nlm.nih.gov/pubmed/35631381
http://dx.doi.org/10.3390/ph15050555

Ejemplares similares